These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14699120)

  • 1. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
    Mahabeleshwar GH; Das R; Kundu GC
    J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
    Chakraborty G; Rangaswami H; Jain S; Kundu GC
    J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant.
    Gupta S; Weiss A; Kumar G; Wang S; Nel A
    J Biol Chem; 1994 Jun; 269(25):17349-57. PubMed ID: 7516337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP potentiates H(2)O(2)-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation.
    Lee K; Esselman WJ
    Cell Signal; 2001 Sep; 13(9):645-52. PubMed ID: 11495722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility.
    Nguyen DH; Hussaini IM; Gonias SL
    J Biol Chem; 1998 Apr; 273(14):8502-7. PubMed ID: 9525964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.
    Nguyen DH; Catling AD; Webb DJ; Sankovic M; Walker LA; Somlyo AV; Weber MJ; Gonias SL
    J Cell Biol; 1999 Jul; 146(1):149-64. PubMed ID: 10402467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
    Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S
    J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.
    Lo RK; Cheung H; Wong YH
    J Biol Chem; 2003 Dec; 278(52):52154-65. PubMed ID: 14551213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
    Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
    J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells.
    Oliveira CJ; Schindler F; Ventura AM; Morais MS; Arai RJ; Debbas V; Stern A; Monteiro HP
    Free Radic Biol Med; 2003 Aug; 35(4):381-96. PubMed ID: 12899940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
    Sliva D; Rizzo MT; English D
    J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.